Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Eli Lilly and Company Limited
Lilly House, Priestley Road, Basingstoke, Hampshire, RG24 9NL
Telephone: +44 (0)1256 315 000
Fax: +44 (0)1256 775 858
WWW: http://www.lilly.co.uk
Medical Information e-mail: ukmedinfo@lilly.com
Medical Information Fax: +44 (0)1256 775 569

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 03/11/2011
PIL Alimta 100mg/500mg powder for concentrate for solution for infusion

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 03/11/2011 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Changes to therapeutic indications
Updated on 16/02/2011 and displayed until 03/11/2011
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
  • Change to side-effects
Updated on 02/12/2009 and displayed until 16/02/2011
Reasons for adding or updating:
  • Change to information for healthcare professionals
  • Change to appearance of the medicine
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Changes to therapeutic indications
Updated on 27/02/2009 and displayed until 02/12/2009
Reasons for adding or updating:
  • Change to date of revision
  • Change to side-effects
Updated on 02/05/2008 and displayed until 27/02/2009
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
  • Change to side-effects
  • Changes to therapeutic indications
Updated on 06/02/2008 and displayed until 02/05/2008
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to date of revision
  • Change of special precautions for disposal
Updated on 02/04/2007 and displayed until 06/02/2008
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Improved Electronic Presentation
  • Change to date of revision
Updated on 08/03/2007 and displayed until 02/04/2007
Reasons for adding or updating:
  • Improved Electronic Presentation
  • Change to side-effects
  • Change to date of revision
Updated on 14/03/2006 and displayed until 08/03/2007
Reasons for adding or updating:
  • Change to side-effects
  • Change to date of revision
Updated on 05/11/2004 and displayed until 14/03/2006
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
  pemetrexed disodium